Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDMesoblast Limited Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.33 | -$0.33 | -$0.33 |
| Q2 2025 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q3 2025 | 1 | -$0.24 | -$0.24 | -$0.24 |
| Q4 2025 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q1 2026 | 1 | -$0.18 | -$0.18 | -$0.18 |
| Q2 2026 | 1 | -$0.37 | -$0.37 | -$0.37 |
| Q3 2026 | 1 | -$0.39 | -$0.39 | -$0.39 |
| Q4 2026 | 1 | -$0.26 | -$0.26 | -$0.26 |
| Q1 2027 | 1 | -$0.19 | -$0.19 | -$0.19 |
| Q2 2027 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q3 2027 | 1 | -$0.27 | -$0.27 | -$0.27 |
| Q4 2027 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q1 2028 | 1 | -$0.28 | -$0.28 | -$0.28 |
| Q2 2028 | 1 | -$0.43 | -$0.43 | -$0.43 |
| Q3 2028 | 1 | -$0.35 | -$0.35 | -$0.35 |
| Q4 2028 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q1 2029 | 1 | -$0.38 | -$0.38 | -$0.38 |
| Q2 2029 | 1 | -$0.24 | -$0.24 | -$0.24 |
| Q3 2029 | 1 | -$0.35 | -$0.35 | -$0.35 |
| Q1 2030 | 1 | $0.10 | $0.10 | $0.10 |
| Q2 2030 | 1 | -$0.25 | -$0.25 | -$0.25 |
| Q1 2031 | 1 | $0.43 | $0.43 | $0.43 |
Mesoblast Limited Earnings Date And Information
Mesoblast Limited last posted its earnings results on Wednesday, February 26th, 2025. The company reported $-0.42 earnings per share for the quarter, missing analysts' consensus estimates of $-0.25 by $0.17. The company had revenue of 1.26 M for the quarter and had revenue of 5.90 M for the year. Mesoblast Limited has generated $0 earnings per share over the last year ($-0.0891 diluted earnings per share) and currently has a price-to-earnings ratio of -16.41. Mesoblast Limited has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
Mesoblast Limited Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/29/2024 | Q4 2024 | N/A | -$0.02 | N/A | $4.08 M | $1.26 M |
| 03/31/2024 | Q3 2024 | N/A | -$0.02 | N/A | N/A | $1.26 M |
| 12/30/2023 | Q2 2024 | N/A | -$0.02 | N/A | N/A | $1.69 M |
| 09/29/2023 | Q1 2024 | N/A | -$0.02 | N/A | $5.60 M | $1.69 M |
| 06/29/2023 | Q4 2023 | N/A | -$0.02 | N/A | $2.38 M | $2.14 M |
| 03/30/2023 | Q3 2023 | N/A | -$0.03 | N/A | N/A | $1.94 M |
| 12/30/2022 | Q2 2023 | N/A | -$0.03 | N/A | $2.10 M | $1.98 M |
| 09/29/2022 | Q1 2023 | N/A | -$0.02 | N/A | $3.47 M | $1.44 M |
| 06/29/2022 | Q4 2022 | N/A | -$0.03 | N/A | $7.59 M | $2.22 M |
| 03/30/2022 | Q3 2022 | N/A | -$0.03 | N/A | $2.10 M | $2.01 M |
| 12/30/2021 | Q2 2022 | N/A | -$0.04 | N/A | $3.50 M | $2.38 M |
| 09/29/2021 | Q1 2022 | N/A | -$0.03 | N/A | $2.35 M | $3.59 M |
| 06/29/2021 | Q4 2021 | N/A | -$0.03 | N/A | $17.71 M | $2.00 M |
| 03/30/2021 | Q3 2021 | N/A | -$0.04 | N/A | $29.20 M | $1.91 M |
| 12/30/2020 | Q2 2021 | N/A | -$0.04 | N/A | $15.63 M | $2.24 M |
| 09/29/2020 | Q1 2021 | N/A | -$0.04 | N/A | $40.58 M | $1.29 M |
| 06/29/2020 | Q4 2020 | N/A | -$0.06 | N/A | $12.71 M | $692,000 |
| 03/30/2020 | Q3 2020 | N/A | -$0.03 | N/A | $9.05 M | $12.08 M |
| 12/30/2019 | Q2 2020 | N/A | -$0.05 | N/A | $4.13 M | $1.97 M |
| 09/29/2019 | Q1 2020 | N/A | -$0.01 | N/A | $2.09 M | $16.87 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Mesoblast Limited Earnings: FAQ's
Mesoblast Limited has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based offlast year's report dates.
The conference call for Mesoblast Limited's latest earnings report can be listened to online.
The conference call transcript for Mesoblast Limited's latest earnings report can be read online.
Mesoblast Limited (:MESO) has a recorded annual revenue of $5.90 M.
Mesoblast Limited (:MESO) has a recorded net income of $-87,956,000.Mesoblast Limited has generated $-0.0891 earnings per share over the last four quarters.
Mesoblast Limited (:MESO) has a price-to-earnings ratio of -16.41 and price/earnings-to-growth ratio is -4.66.